To evaluate the efficacy and safety of oral sitafloxacin versus oral moxifloxacin in the treatment of Chinese adults with community-acquired pneumonia (CAP). This is a multicenter, randomized, open-la
This is a ST59-type CA-MRSA sensitive to moxifloxacin, which caused a community-acquired pneumonia in a 60-year-old Chinese male who was cured by moxifloxacin treatment
OBJECTIVE: To determine the incidence rate and mortality of community-acquired pneumonia (CAP) in adults in three cities in Latin America during a three-year period. DESIGN: Prospective population b
